chartexchange

PMVP
PMV Pharmaceuticals, Inc
stockNASDAQ

At CloseNov 18, 2026 3:59:54 PM EST
1.23USD+0.820%(+0.01)430,867
Pre-marketNov 18, 2026 8:55:30 AM EST
1.22USD0.000%(0.00)
After-hoursNov 18, 2026 4:39:30 PM EST
1.24USD+0.813%(+0.01)
Loading…
Loading…
Healthcare
Biotechnology
HQ
Cranbury, NJ, USA
Previous Close
$1.22
Beta
0.70
52-Week High
$1.91 2026-10-01
52-Week Low
$1.02 2026-02-23
SMA 50
$1.38
SMA 200
$1.31
Avg. Vol 10D
397,933
Avg. Vol 30D
428,860
Avg. Vol 90D
584,110
Relative Vol
1.00
48.90M
1.2200%
6,300,000
623
PMVP Profile

pmv pharmaceuticals, inc., a precision oncology company, discovery and development of small molecule, tumor-agnostic therapies for p53 mutations in cancer. its lead product candidate is pc14586, a small molecule that corrects and restores p53 function. the company also develops product candidates for p53 r273h hotspot mutation and other p53 hotspot mutations. pmv pharmaceuticals, inc. was formerly known as pj pharmaceuticals, inc. and changed to in july 2013. the company was founded in 2013 and is headquartered in cranbury, new jersey.

PMVP Performance
PeriodPriceDateChangeBeta
1W1.212026-11-12+1.65%5.211
1M1.262026-10-19-1.99%0.907
3M1.282026-08-19-3.91%0.615
6M1.312026-05-19-6.11%0.648
1Y1.362025-11-19-9.56%0.698
2Y1.592024-11-19-22.64%—
5Y25.122021-11-19-95.10%1.125
PMVP Stock Summary

PMV Pharmaceuticals, Inc (NASDAQ:PMVP) stock price today is $1.23, and today's volume is 430,867. PMVP is up 0.820% today. The 30 day average volume is 428,860. PMVP market cap is $92.91M with 75.53M shares outstanding.